Found: 5
Select item for more details and to access through your institution.
Multilayered proteomics reveals that JAM‐A promotes breast cancer progression via regulation of amino acid transporter LAT1.
- Published in:
- Cancer Science, 2024, v. 115, n. 9, p. 3153, doi. 10.1111/cas.16259
- By:
- Publication type:
- Article
Aberrant expression of claudin‐6 contributes to malignant potentials and drug resistance of cervical adenocarcinoma.
- Published in:
- Cancer Science, 2022, v. 113, n. 4, p. 1519, doi. 10.1111/cas.15284
- By:
- Publication type:
- Article
Aberrant expression of junctional adhesion molecule‐A contributes to the malignancy of cervical adenocarcinoma by interaction with poliovirus receptor/CD155.
- Published in:
- Cancer Science, 2021, v. 112, n. 2, p. 906, doi. 10.1111/cas.14734
- By:
- Publication type:
- Article
Aldolase A promotes epithelial‐mesenchymal transition to increase malignant potentials of cervical adenocarcinoma.
- Published in:
- Cancer Science, 2020, v. 111, n. 8, p. 3071, doi. 10.1111/cas.14524
- By:
- Publication type:
- Article
Elevated expression of JAM-A promotes neoplastic properties of lung adenocarcinoma.
- Published in:
- Cancer Science, 2017, v. 108, n. 11, p. 2306, doi. 10.1111/cas.13385
- By:
- Publication type:
- Article